Zions Bancorporation’s MiMedx Group MDXG Stock Holding History

Zions Bancorporation’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-250	Closed	-$1K	–	1020
2022 Q2	$1K	Buy	+250	New	+$979	﹤0.01%	1034

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BMO

Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zions Bancorporation's MDXG Position: Q3 2022 in Review

Zions Bancorporation sold out of MiMedx Group (MDXG) in Q3 2022, closing a stake of 250 shares — an estimated $1K sold.

Zions Bancorporation first reported a position in MDXG in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 144 funds tracked by Wall St. Rank hold MDXG as of Q3 2022.

Zions Bancorporation reported no remaining MiMedx Group position as of Q3 2022 after selling out during the quarter.
Zions Bancorporation sold 250 MiMedx Group shares in Q3 2022, an estimated $1K.
Zions Bancorporation first reported a position in MiMedx Group in Q2 2022 and held it in 1 quarter.
Zions Bancorporation's MiMedx Group position peaked at $1K in Q2 2022.
144 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2022.

Based on Zions Bancorporation's 13F filing for Q3 2022, filed 8 Nov 2022.